Epigenetic Changes Associated With Anthracycline‐Induced Cardiotoxicity

Abstract excerpt

Advances in cancer treatment have significantly improved the survival of patients with cancer, but, unfortunately, many of these treatments also have long-term complications. Cancer treatment-related cardiotoxicities are becoming a significant clinical problem that a new discipline, Cardio-Oncology, was established to advance the cardiovascular care of patients with growing cancer populations. Anthracyclines are...

Topics

Join the communities discussing this publication.

• Cancer-related cognitive impairment studies
• Chemotherapy-induced cardiotoxicity and mitigation
• Chemotherapy-induced organ toxicity mitigation